title: Oncogene products and other diagnostic markers in human breast cancer patients. Treatment effects and their significance.
authors.affiliation: Academic Department of Biochemistry, Royal Marsden Hospital, London, England.
authors.forename: M
authors.initials: M
authors.lastname: Dowsett
authors.forename: A
authors.initials: A
authors.lastname: Makris
authors.forename: P
authors.initials: P
authors.lastname: Ellis
authors.forename: S R
authors.initials: SR
authors.lastname: Johnston
authors.forename: J
authors.initials: J
authors.lastname: Salter
authors.forename: S
authors.initials: S
authors.lastname: Detre
authors.forename: S
authors.initials: S
authors.lastname: Humphries
authors.forename: G
authors.initials: G
authors.lastname: Saccani-Jotti
authors.forename: T J
authors.initials: TJ
authors.lastname: Powles
authors.forename: I E
authors.initials: IE
authors.lastname: Smith
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins / Q000032:analysis; D009687:Nuclear Proteins / Q000032:analysis; D015513:Oncogene Proteins / Q000032:analysis*; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D009687:Nuclear Proteins; D015513:Oncogene Proteins; D011960:Receptors, Estrogen; D013629:Tamoxifen